Why the answer is 4: Withhold the drug and report the drowsiness and headache
In a patient with advanced COPD, the combination of new-onset drowsiness, headache, and a reduced respiratory rate of
12/min while already receiving supplemental oxygen is a clinical red flag. These findings suggest
carbon dioxide narcosis—a state in which rising arterial CO₂ from hypoventilation depresses the central nervous system. The patient’s baseline ABG from
3 months ago reflects his stable compensated state, but the current presentation indicates acute deterioration on top of chronic retention.
Benzodiazepines such as diazepam act as central nervous system depressants that blunt the ventilatory drive, particularly the hypoxic and hypercapnic responses that a COPD patient relies on to maintain breathing. In a patient already showing signs of CO₂ retention, administering diazepam—even at half the prescribed dose—can further suppress respiratory effort and precipitate acute hypercapnic respiratory failure. The risk is not merely theoretical; it is a direct pharmacodynamic interaction between the sedative and an already compromised respiratory control system.
The patient’s as-needed diazepam order was written for insomnia, but the current clinical picture is not simple sleeplessness.
Watch out! New headache and drowsiness in a COPD patient on oxygen are not benign symptoms of anxiety or fatigue—they are early neurologic manifestations of hypercapnia. Treating them with a sedative would mask the underlying deterioration while simultaneously worsening its cause.
The safest nursing action is to hold the benzodiazepine and promptly communicate the change in mental status, headache, and respiratory pattern to the physician, who can reassess with a repeat ABG and adjust ventilatory support or oxygen therapy. Delaying the report to recheck the patient in
30 minutes or
1 hour after giving the drug creates a dangerous window during which respiratory failure could progress unnoticed.
| Option | Why it is incorrect |
|---|
| 1. Give the drug and recheck in 30 minutes | Administers a respiratory depressant to a patient already showing signs of hypoventilation; rechecking later does not prevent the initial harm. |
| 2. Give half the dose and recheck in 1 hour | Dose reduction does not eliminate the risk of further respiratory depression in a vulnerable COPD patient; the delay in reassessment compounds the danger. |
| 3. Give the drug and keep in high Fowler’s position | Positioning may aid lung expansion, but it cannot counteract the central respiratory depressant effect of diazepam in a patient with suspected CO₂ narcosis. |
| 4. Withhold the drug and report the drowsiness and headache | Correct. Prevents additional ventilatory suppression and triggers timely medical reassessment, including possible repeat ABG. |
The role of the nurse in this scenario is to recognize that the patient’s request for sleep medication is secondary to a more urgent physiologic problem.
Key point! In COPD, a falling respiratory rate with drowsiness and headache indicates that the patient is retaining CO₂; any sedative-hypnotic must be withheld until the cause is clarified and the patient’s ventilatory status is stabilized. The physician’s order for a repeat ABG on admission supports the expectation that objective gas exchange data will guide further decisions, but the immediate nursing priority is to avoid adding a respiratory depressant and to escalate the concerning findings without delay.